Marketing-authorisation holder · Ireland
Novartis Europharm Limited
733 medicines in 5 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Ireland
733 medicines in 5 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 733
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Afinitor | Everolimus | EU (EMA) | Authorised | 2009 |
| AFINITORCompressa | Everolimus | Italy | Authorised | |
| AFINITOR 10 MG COMPRIMIDOS10 mg · Comprimido | Everolimus | Spain | Marketed | 2009 |
| Afinitor 10 mg, tablettenTablet | Everolimus | Netherlands | Authorised | 2009 |
| Afinitor 2,5 mg, tablettenTablet | Everolimus | Netherlands | Authorised | 2012 |
| AFINITOR 5 MG COMPRIMIDOS5 mg · Comprimido | Everolimus | Spain | Marketed | 2009 |
| Afinitor 5 mg, tablettenTablet | Everolimus | Netherlands | Authorised | 2009 |
| AIMOVIGSoluzione iniettabile | Erenumab | Italy | Authorised | |
| Aimovig | Erenumab | EU (EMA) | Authorised | 2018 |
| Aimovig 140 mg oplossing voor injectie in voorgevulde penOplossing voor injectie | Erenumab | Netherlands | Authorised | 2019 |
| Aimovig 140 mg oplossing voor injectie in voorgevulde spuitOplossing voor injectie | Erenumab | Netherlands | Authorised | 2019 |
| AIMOVIG 140 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA140 mg · Solución inyectable en pluma precargada | Erenumab | Spain | Marketed | 2019 |
| AIMOVIG 140 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA140 mg · Solución inyectable en pluma precargada | Erenumab | Spain | Authorised | 2026 |
| Aimovig 70 mg oplossing voor injectie in voorgevulde penOplossing voor injectie | Erenumab | Netherlands | Authorised | 2018 |
| Aimovig 70 mg oplossing voor injectie in voorgevulde spuitOplossing voor injectie | Erenumab | Netherlands | Authorised | 2018 |
| AIMOVIG 70 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA70 mg · Solución inyectable en pluma precargada | Erenumab | Spain | Marketed | 2018 |
| Atectura Breezhaler | Indacaterol, Mometasone | EU (EMA) | Authorised | 2020 |
| ATECTURA BREEZHALERPolvere per inalazione, capsula rigida | Indacaterol, Mometasone | Italy | Authorised | |
| Atectura Breezhaler 125 microgram/127,5 microgram inhalatiepoeder in harde capsulesInhalatiepoeder in harde capsule | Indacaterol, Mometasonfuroaat | Netherlands | Authorised | 2020 |
| Atectura Breezhaler 125 microgram/260 microgram inhalatiepoeder in harde capsulesInhalatiepoeder in harde capsule | Indacaterol, Mometasonfuroaat | Netherlands | Authorised | 2020 |
| Atectura Breezhaler 125 microgram/62,5 microgram inhalatiepoeder in harde capsulesInhalatiepoeder in harde capsule | Indacaterol, Mometasonfuroaat | Netherlands | Authorised | 2020 |
| ATECTURA BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)0,173 mg + 0,160 mg · Polvo para inhalación (cápsula dura) | Indacaterol, Mometasone | Spain | Marketed | 2020 |
| ATECTURA BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA)0,173 mg + 0,320 mg · Polvo para inhalación (cápsula dura) | Indacaterol, Mometasone | Spain | Marketed | 2020 |
| ATECTURA BREEZHALER 125 microgramos/62,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)0,173 mg + 0,080 mg · Polvo para inhalación (cápsula dura) | Indacaterol, Mometasone | Spain | Marketed | 2020 |
| Azarga | Brinzolamide, Timolol | EU (EMA) | Authorised | 2008 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 247 | 234 | 13 | CompaniesAll medicines |
| Netherlands | 180 | 180 | 0 | CompaniesAll medicines |
| Romania | 136 | 0 | 136 | CompaniesAll medicines |
| European Union (EMA) | 99 | 73 | 26 | CompaniesAll medicines |
| Italy | 71 | 71 | 0 | CompaniesAll medicines |
Also in the registers of France
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.